July 2, 2022

Volume XII, Number 183


Robert A. Cantone

Robert A. Cantone, a partner in the Corporate Department, advises life science companies on their important transactional and securities matters. Robert has significant experience representing public and private companies, particularly in the life sciences sector, in acquisitions, divestitures, and other major corporate transactions, including domestic and cross-border collaborations, co-promotions, licenses, and distribution arrangements. Due to the breadth of his experience in structuring and negotiating mergers and acquisitions, strategic partnerships and commercial transactions, Robert is an effective partner to his clients’ senior management teams in the execution of high value transactions.

As an advisor to public companies, Robert also assists clients with numerous securities law compliance matters, particularly public disclosures regarding a wide range of important corporate developments, including strategic transactions, clinical trials, government investigations, and civil litigation, as well as corporate governance matters, including board of directors’ oversight of corporate compliance with laws regulating the businesses of life science companies.


Articles in the National Law Review database by Robert A. Cantone